One Global Service Provider Limited engages in the provision of healthcare services worldwide. The company offers diagnostic services, including anemia, antenatal, diabetes, diabetes monitoring, hypertension, kidney, and lipid profiles, as well as liver function tests; and healthcare services, such as end-to-end solutions in industrial occupational check-ups, population screening for non-communicable diseases, disease surveillance programs, electronic medical records and health registry, health analytics for predictive and preventive actions, and wellness programs for lifestyle diseases. It also provides laboratory services, such as biochemistry, microbiology, hematology and coagulation, histopathology and cytopathology, clinical pathology, molecular diagnostics, and serology. In addition, the company offers healthcare products, such as medical devices, equipment, medical consumables, and reagents through an online platform; and healthcare solutions comprising home-based health screening, public health data analytics, and home-based remote care services. Further, it is involved in the consultancy and development, requirements, designing, developing, testing, integrating, deploying, and maintaining of software/IT products; and purchasing, sale, distribution of licenses, resale, import, export of IT and software products. The company was formerly known as Overseas Synthetics Limited. One Global Service Provider Limited was incorporated in 1992 and is based in Mumbai, India.
Metrics to compare | ONEG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipONEGPeersSector | |
---|---|---|---|---|
P/E Ratio | 20.6x | 15.7x | 11.2x | |
PEG Ratio | 3.69 | −4.81 | 0.02 | |
Price/Book | 7.6x | 0.6x | 1.4x | |
Price / LTM Sales | 2.5x | 0.8x | 1.0x | |
Upside (Analyst Target) | - | 33.5% | 19.0% | |
Fair Value Upside | Unlock | 9.2% | 9.7% | Unlock |